AI Antimicrobial Resistance Drug Repurposing

Machine Learning Prediction of Antibiotic Efficacy Against Resistant Pathogens

This research investigates how machine learning algorithms can predict which existing antimicrobial compounds will remain effective against drug-resistant bacterial strains by analyzing molecular structure and resistance mechanisms. The work produces validated computational models that accelerate identification of repurposable antibiotics and reduce time-to-treatment for resistant infections.

Deep Learning Analysis of Resistance Gene Expression Patterns in Bacteria

This research explores deep neural networks to decode how bacteria activate and regulate resistance genes in response to antimicrobial compounds, using genomic and transcriptomic datasets. The study generates predictive biomarkers that identify which drugs can overcome specific resistance pathways in individual pathogens.

Artificial Intelligence Screening of FDA-Approved Compounds for Synergistic Antimicrobial Combinations

This research applies AI algorithms to systematically screen existing pharmaceutical libraries for drug combinations that show synergistic antimicrobial activity against resistant organisms through computational molecular docking and interaction prediction. The findings identify novel multi-drug therapies with minimal development time and established safety profiles.

Structural Bioinformatics Prediction of Emerging Resistance Mechanisms to Repurposed Drugs

This research uses computational protein structure modeling and molecular dynamics simulations to predict how bacteria will evolve resistance against repurposed antimicrobial compounds before clinical emergence. The work provides insights into rational drug design and pre-emptive combination strategies to prevent future resistance.

Natural Language Processing of Antimicrobial Literature for Hidden Drug Repurposing Opportunities

This research applies NLP and text mining to decades of antimicrobial and pharmacology literature to uncover forgotten or overlooked compounds with potential against resistant pathogens. The analysis generates comprehensive research maps that reveal previously disconnected scientific findings relevant to modern resistance challenges.

Metabolic Pathway Modeling of Resistance Evasion by Repurposed Antimicrobial Agents

This research builds computational metabolic network models to understand how bacteria circumvent antimicrobial action and uses AI to identify repurposed compounds that simultaneously target multiple evasion pathways. The study produces mechanistic insights that enable rational combination therapy design against multidrug-resistant organisms.

Graph Neural Networks for Predicting Antimicrobial-Resistance Gene Interactions

This research develops graph-based machine learning to model complex interactions between resistance genes and antimicrobial compounds as network structures, revealing hidden dependencies and vulnerabilities. The approach generates novel hypotheses about resistance mechanisms and identifies compounds that disrupt critical gene regulatory networks.

Evolutionary Computation Algorithms for Multi-Objective Antimicrobial Drug Optimization

This research uses genetic algorithms and multi-objective optimization to simultaneously maximize antimicrobial potency, minimize toxicity, and reduce resistance risk for repurposed compounds. The computational framework produces candidate drugs that balance clinical efficacy, safety, and long-term resistance sustainability.

Chemoinformatics Clustering of Antimicrobial Compounds with Novel Resistance Penetration Mechanisms

This research applies machine learning-based molecular fingerprinting and clustering to categorize antimicrobial compounds by their structural ability to penetrate resistant bacterial barriers like biofilms and cell walls. The classification system identifies underexplored compound classes with intrinsic advantages against conventionally resistant pathogens.

Bayesian Network Analysis of Clinical Antimicrobial Resistance Outcomes and Drug Repurposing Success

This research constructs probabilistic graphical models to identify causal relationships between patient factors, resistance profiles, and treatment outcomes for repurposed antimicrobials in clinical datasets. The analysis produces predictive tools that identify which resistant infections are most likely to respond to specific repurposed therapies.